NCT01299610View on ClinicalTrials.gov

A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 1, 2010

Primary Completion Date

March 1, 2011

Study Completion Date

April 14, 2011

Conditions
Dermatitis, Atopic
Interventions
DRUG

GW870086 2.0%

White to slightly colored opaque cream

DRUG

GW870086 0.2%

White to slightly colored opaque cream

DRUG

FP 0.05%

White cream

DRUG

Placebo

White to slightly colored opaque cream

Trial Locations (1)

10117

GSK Investigational Site, Berlin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01299610 - A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo | Biotech Hunter | Biotech Hunter